Cite

    Criscitiello, C., Bayar, M. A., Curigliano, G., Symmans, F. W., Desmedt, C., Bonnefoi, H., Sinn, B., Pruneri, G., Vicier, C., Pierga, J. Y., Denkert, C., Loibl, S., Sotiriou, C., Michiels, S., & André, F. (2018). a gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer. Annals of oncology, 29, 162–169. http://access.bl.uk/ark:/81055/vdc_100095498197.0x000034